- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6809 - Methods for determination or identification of nucleic acids involving differential detection
Patent holdings for IPC class C12Q 1/6809
Total number of patents in this class: 2590
10-year publication summary
197
|
178
|
105
|
221
|
265
|
269
|
253
|
216
|
197
|
131
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Prognosys Biosciences, Inc. | 95 |
62 |
The Board of Trustees of the Leland Stanford Junior University | 6114 |
38 |
The Chinese University of Hong Kong | 630 |
37 |
The Regents of the University of California | 19182 |
33 |
Verinata Health, Inc. | 93 |
33 |
University Health Network | 992 |
32 |
President and Fellows of Harvard College | 5838 |
30 |
Sequenom, Inc. | 276 |
30 |
Natera, Inc. | 270 |
29 |
Illumina, Inc. | 2932 |
28 |
Dana-Farber Cancer Institute, Inc. | 2499 |
27 |
The Chinese University of Hong Kong | 148 |
26 |
Massachusetts Institute of Technology | 9837 |
23 |
The Johns Hopkins University | 5428 |
21 |
Becton, Dickinson and Company | 6896 |
18 |
The General Hospital Corporation | 4575 |
18 |
Toray Industries, Inc. | 6737 |
18 |
The Broad Institute, Inc. | 1638 |
18 |
Genentech, Inc. | 3754 |
15 |
Centre National de La Recherche Scientifique | 9814 |
15 |
Other owners | 2039 |